Skip to main content

Day: December 30, 2019

AFARAK GROUP OYJ:N TALOUDELLINEN RAPORTOINTI VUONNA 2020

16:00 Lontoo, 18:00 Helsinki, 30.12.2019 – Afarak Group Oyj (”Afarak” tai ”Yhtiö) (LSE: AFRK, NASDAQ: AFAGR)AFARAK GROUP OYJ:N TALOUDELLINEN RAPORTOINTI VUONNA 2020PörssitiedoteAfarak Group Oyj (“Afarak” tai “Yhtiö”) julkistaa tulosraporttinsa seuraavasti:– Vuoden 2019 tilinpäätöstiedote perjantaina 28.2.2020– Vuoden 2019 vuosikertomus 30. maaliskuuta 2020 alkavalla viikolla– Osavuosikatsaus tammi-kesäkuulta perjantaina 21.8.2020Varsinainen yhtiökokous on suunniteltu pidettäväksi tiistaina 26.5.2020. Varsinaiseen yhtiökokoukseen julkaistaan erillinen kutsu määräajassa vuonna 2020.Tuotantoraportit tullaan julkaisemaan neljännesvuosittain.Helsingissä, 30.12.2019Afarak Group OyjHallitusLisätietoja:Guy...

Continue reading

BRAVO MULTINATIONAL INCORPORATED (BRVO) Announces a “LETTER OF INTENT” to Acquire ELEMENT GLOBAL, INC.’s (ELGL) Subsidary ELEMENT GLOBAL MINING

VIRGINIA BEACH, Va., Dec. 30, 2019 (GLOBE NEWSWIRE) — BRAVO MULTINATIONAL INCORPORATED (OTC:BRVO) and ELEMENT GLOBAL, INC. (OTC.ELGL) announces a “Letter of Intent,” whereas BRVO acquires ELGL’s subisidiary, ELEMENT GLOBAL MINING (EGM).The “Letter of Intent” provided for negotiations and due diligence, with an expected outcome of an acquisition of ELEMENT GLOBAL MINING (EGM). BRVO believes this acquisition should bring significant value to the Company and its shareholders.For further information about this release, contact Investor Relations, YES INTERNATIONAL, at 757-306-6090 and yes@yesinternational.com, www.elementglobal.com and www.bravomultinational.com.Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking...

Continue reading

Veloxis Pharmaceuticals Announces Financial Calendar for 2020

Company Release no. 23/2019To: NASDAQ Copenhagen A/S                                                             Copenhagen, Denmark, 30 December 2019 Veloxis Pharmaceuticals Announces Financial Calendar for 2020 Veloxis Pharmaceuticals A/S (OMX: VELO) today announced its financial calendar for 2020. The full calendar is shown below. For more information, please contact: About Veloxis PharmaceuticalsVeloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant...

Continue reading

Update: DNO ASA: Mandatory Notification of Trade

Oslo, 30 December 2019 – DNO ASA, the Norwegian oil and gas operator, has today purchased 1,200,000 own shares at an average price of NOK 11.5543 per share. Following this transaction, DNO holds 95,700,000 own shares.—For further information, please contact:—DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Netherlands, Ireland and Yemen.This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Continue reading

Cost relating to changes at Valitor in order to turn around the company’s losses estimated around ISK 600 million in Q4 2019

The Board of Directors of Valitor, a subsidiary of Arion Bank, has decided to undertake a reorganisation of the company in order to strengthen Valitor’s core business and to turn around the company’s losses. Cost relating to the changes is expected to be around ISK 600 million which will be reflected in Arion Bank’s Q4 financial results. The expected measures will take the company from an operating loss to an EBITDA profit.  Further details will be announced by Valitor within two weeks’ time. Valitor’s investments in international operations have been considerable in recent years. These investments have led to revenue growth, but sales of omni-channel solutions – a product line for large pan-European companies – have not met expectations. Compared to a total investment of ISK 6 billion...

Continue reading

Kostnaður við breytingar hjá Valitor til að snúa við taprekstri áætlaður um 600 milljónir króna á 4. ársfjórðungi 2019

Stjórn Valitor, dótturfélag Arion banka, hefur ákveðið að ráðast í endurskipulagningu á félaginu til að styrkja kjarnastarfsemi þess og snúa við taprekstri. Kostnaður við breytingarnar er áætlaður 600 milljónir króna og verður bókfærður í uppgjöri Arion banka samstæðunnar fyrir 4. ársfjórðung 2019. Gert er ráð fyrir að þessar aðgerðir Valitor breyti afkomu félagsins úr tapi yfir í rekstrarhagnað fyrir afskriftir og fjármagnsliði (e. EBITDA). Valitor mun greina nánar frá inntaki fyrirhugaðra breytinga innan tveggja vikna.Fjárfestingar Valitor í alþjóðlegri...

Continue reading

Mkango Announces Results of Annual General Meeting

LONDON and VANCOUVER, British Columbia, Dec. 30, 2019 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango“) is pleased to announce that shareholders have approved all resolutions at the Annual General Meeting (the “Meeting”) held in Toronto today.All business put forth at the Meeting was approved by shareholders of the Company, including:–              the election of Derek Linfield, William Dawes, Alexander Lemon, Adrian Reynolds, Susan Muir, Sandra du Toit and Shaun Treacy as Directors of the Company;–              re-appointment of MNP LLP as auditors of the Company; and–             ...

Continue reading

Andersen & Martini Holding A/S Selskabsmeddelelse nr. 6 2019 Finanskalender 2020

 Nasdaq OMX Copenhagen A/S                                Meddelelse nr.          6 /2019 Nikolaj Plads 6                                                           Fondskode DK 0010283597 1067 København K                                 ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.